Ms.Medicine and Genetesis today announced the start of a clinical registry for Women’s Assessed Cardiovascular Evaluation with Magnetocardiography (WACE-MCG).
The WACE-MCG registry is designed to compare the usual approach of diagnosing and evaluating patients with an elevated risk of Cardiovascular Disease (CVD) with the results of a CardioFlux scan, a novel device that provides a biomagnetic view of cardiac function. The WACE-MCG registry will evaluate whether a CardioFlux scan can improve the outcomes, effectiveness and cost of monitoring patients at risk of CVD. CardioFlux utilizes no radiation, is completely contactless and is done in less than 5 minutes. The registry will enroll up to 200 Ms.Medicine patients at Mason’s CardioFlux Imaging Institute, a collaborative initiative between Genetesis and the City of Mason, to demonstrate that this technology will create a faster, less invasive and more patient-centric standard of care.